5-Day Preoperative Radiation for Soft Tissue Sarcoma
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Stanford University
- Study ID
- NCT06087861
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Soft Tissue Sarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- External Beam Radiotherapy — RADIATIONRadiation will be delivered by external beam techniques to the tumor and areas of possible microscopic disease at a dose of 30 Gy divided into 5 equal fractions of 6 Gy (administered over a total of 5 to 10 business day
Study Details
The purpose of this study is to examine the safety and efficacy of an abbreviated course of preoperative radiation, given over five days, for patients with soft tissue sarcoma of the extremity, trunk or retroperitoneum. This is in contrast to standard preoperative radiation, which is given over 25 days.
Key Dates
- Start date
- Oct 6, 2023
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 75 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: External beam radiotherapyPatients will receive treatment with external beam radiotherapy at a total of 30 Gy delivered over five fractions delivered daily.
Primary Outcome Measure
Post-operative Complication Rate [ Time Frame: 120 days after surgery ]
Central Contacts
- Alyssa Yauger650-498-5271
- Aastha Dubey650-725-2084
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University | Palo Alto | California | 94305 | Anusha Kalbasi, M.D. (PRINCIPAL_INVESTIGATOR) Everett Moding (SUB_INVESTIGATOR) Susie Hiniker (SUB_INVESTIGATOR) |
Find similar trials in Palo Alto, CA
By research site
Related Studies
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyPHASE4 · Enrolling By Invitation · Massachusetts General Hospital · Los Angeles, California
- Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)PHASE3 · Recruiting · Polaris Group · Phoenix, Arizona
- Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational StudyNot Yet Recruiting · Power Life Sciences Inc. · San Francisco, California
- A Study of MT-4561 in Patients With Various Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Tanabe Pharma America, Inc. · Los Angeles, California